Literature DB >> 29427051

The complex interplay between neutrophils and cancer.

Andrea Rakic1,2,3, Paul Beaudry1,2,4, Douglas J Mahoney5,6,7,8.   

Abstract

Neutrophils are the most abundant type of white blood cell, and are an essential component of the innate immune system. They characteristically arrive rapidly at sites of infection and injury, and release a variety of cytokines and toxic molecules to eliminate pathogens and elicit an acute inflammatory response. Research into the function of neutrophils in cancer suggest they have divergent roles. Indeed, while most studies have found neutrophils to be associated with cancer progression, others have also documented anticancer effects. In this review, we describe the investigations into neutrophil populations that have been implicated in promoting tumor growth and metastasis as well those demonstrating antitumor functions. The collective research suggests a complex role for neutrophils in cancer biology, which raises the prospect of their targeting for the treatment of cancer.

Entities:  

Keywords:  Cancer biomarker; Immunosuppression; Metastasis; Neutrophil polarization; Neutrophil targeted therapies; Tumor-associated neutrophils

Mesh:

Year:  2018        PMID: 29427051     DOI: 10.1007/s00441-017-2777-7

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  13 in total

Review 1.  The emerging roles of macrophages in cancer metastasis and response to chemotherapy.

Authors:  Luis Rivera Sanchez; Lucia Borriello; David Entenberg; John S Condeelis; Maja H Oktay; George S Karagiannis
Journal:  J Leukoc Biol       Date:  2019-02-05       Impact factor: 4.962

2.  Construction of a ceRNA network in hepatocellular carcinoma and comprehensive analysis of immune infiltration patterns.

Authors:  Zhifan Zuo; Tingsong Chen; Yue Zhang; Lei Han; Bo Liu; Bin Yang; Tao Han; Zhendong Zheng
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

3.  Polymorphonuclear Neutrophils and Tumors: Friend or Foe?

Authors:  Izabela Szulc-Kielbik; Magdalena Klink
Journal:  Exp Suppl       Date:  2022

4.  Construction of a competing endogenous RNA network related to the prognosis of cholangiocarcinoma and comprehensive analysis of the immunological correlation.

Authors:  Ning Wang; Yinghui Zhou; Zhifan Zuo; Ruoyu Wang; Jing Li; Tao Han; Bin Yang
Journal:  J Gastrointest Oncol       Date:  2021-10

Review 5.  Mechanistic insights into the interplays between neutrophils and other immune cells in cancer development and progression.

Authors:  Zimam Mahmud; Atiqur Rahman; Israt Dilruba Mishu; Yearul Kabir
Journal:  Cancer Metastasis Rev       Date:  2022-03-21       Impact factor: 9.237

6.  Systemic immune-inflammation index as a prognostic marker in patients with newly diagnosed metastatic nasopharyngeal carcinoma: a propensity score-matched study.

Authors:  Cheng Lin; Sheng Lin; Qiao-Juan Guo; Jing-Feng Zong; Tian-Zhu Lu; Na Lin; Shao-Jun Lin; Jian-Ji Pan
Journal:  Transl Cancer Res       Date:  2019-09       Impact factor: 1.241

Review 7.  Role of tumor-associated immune cells in prostate cancer: angel or devil?

Authors:  Shui-Qing Wu; Hao Su; Yin-Huai Wang; Xiao-Kun Zhao
Journal:  Asian J Androl       Date:  2019 Sep-Oct       Impact factor: 3.285

Review 8.  Predictive biomarkers for tumor immune checkpoint blockade.

Authors:  Mengting Tong; Jing Wang; Wenting He; Yanling Wang; Hongming Pan; Da Li; Hongliang Zhang
Journal:  Cancer Manag Res       Date:  2018-10-11       Impact factor: 3.989

Review 9.  Plasticity in Pro- and Anti-tumor Activity of Neutrophils: Shifting the Balance.

Authors:  Charita Furumaya; Paula Martinez-Sanz; Panagiota Bouti; Taco W Kuijpers; Hanke L Matlung
Journal:  Front Immunol       Date:  2020-09-02       Impact factor: 7.561

10.  Regulatory Interactions Between Neutrophils, Tumor Cells and T Cells.

Authors:  Hans-Heinrich Oberg; Daniela Wesch; Shirin Kalyan; Dieter Kabelitz
Journal:  Front Immunol       Date:  2019-07-18       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.